Macrophage activation syndrome associated with adult-onset Still's disease

6Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Macrophage activation syndrome (MAS) is a rare and potentially lethal disease, resulting from uncontrolled activation and proliferation of T lymphocytes and macrophages. Adult-onset Still's disease (AOSD) is an inflammatory disease. AOSD resemble reactive MAS in its symptoms and laboratory data. Moreover, AOSD per se induces MAS. It is, therefore, quite difficult to differentiate these syndrome and disease. The immunodeficiency state induced by treatment in AOSD could reactivate latent viruses such as Epstein-Barr virus, which could potentially lead to MAS. The therapeutic agents for AOSD, such as sulfasalazine, also could provoke reactive MAS. Because multiple factors are involved in inducing MAS to a different degree, the main cause should be searched for and targeted for the therapy. © 2007, The Japan Society for Clinical Immunology. All rights reserved.

Cite

CITATION STYLE

APA

Iwamoto, M. (2007). Macrophage activation syndrome associated with adult-onset Still’s disease. Japanese Journal of Clinical Immunology, 30(6), 428–431. https://doi.org/10.2177/jsci.30.428

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free